InvestSMART

Micro-X Limited (ASX: MX1) - Announcements

Current share price for MX1 : $0.019 0.002 (11.76%)+

ASX company news and announcements for Micro-X Limited (MX1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Micro-X Limited (MX1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Micro-X Limited (MX1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Micro-X Limited (MX1)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$14 MX1 - Notice Under Section 708A(5) of the Corporations Act 16 Jun 2026 1:44PM $0.037 $0.019 fallen by 47.95%
$14 MX1 - Micro-X to Receive $1.3m for Lung CT Scanner Research 16 Jun 2026 9:24AM $0.035 $0.019 fallen by 45.71%
$14 MX1 - Micro-X Completes Full Body CT Critical Design Review 10 Jun 2026 9:43AM $0.038 $0.019 fallen by 50%
$14 MX1 - HealthInvest Presentation 3 Jun 2026 5:37PM $0.038 $0.019 fallen by 50%
$14 MX1 - Human Imaging Study Commences with Micro-X Head CT 3 Jun 2026 12:06PM $0.038 $0.019 fallen by 50%
$14 Notification of cessation of securities - MX1 1 Jun 2026 6:52PM $0.041 $0.019 fallen by 53.66%
$14 Change in substantial holding 1 Jun 2026 4:29PM $0.041 $0.019 fallen by 53.66%
$14 MX1 - Notice Under Section 708A(5) of the Corporations Act 19 May 2026 4:00PM $0.046 $0.019 fallen by 58.70%
$14 Application for quotation of securities - MX1 19 May 2026 3:57PM $0.046 $0.019 fallen by 58.70%
$14 $1.3m Checkpoint Contract Extension Awarded by DHS 19 May 2026 9:15AM $0.043 $0.019 fallen by 55.81%
$14 MX1 - Quarterly Activities Report & Appendix 4C 30 Apr 2026 12:45PM $0.054 $0.019 fallen by 64.81%
$14 Change of Director's Interest Notice - Patrick OBrien 27 Apr 2026 1:36PM $0.059 $0.019 fallen by 67.80%
$14 MX1 - Notice Under Section 708A(5) of the Corporations Act 27 Apr 2026 1:05PM $0.060 $0.019 fallen by 68.33%
$14 Application for quotation of securities - MX1 27 Apr 2026 12:11PM $0.058 $0.019 fallen by 67.24%
$14 MX1 - Notice Under Section 708A(5) of the Corporations Act 20 Apr 2026 6:38PM $0.057 $0.019 fallen by 66.67%
$14 Application for quotation of securities - MX1 20 Apr 2026 6:37PM $0.057 $0.019 fallen by 66.67%
$14 Notification of cessation of securities - MX1 20 Apr 2026 5:21PM $0.057 $0.019 fallen by 66.67%
$14 Notification regarding unquoted securities - MX1 20 Apr 2026 5:18PM $0.057 $0.019 fallen by 66.67%
$14 MX1 - Appointment of Chief Financial Officer 27 Mar 2026 9:20AM $0.057 $0.019 fallen by 66.67%
$14 MX1 - Results of Meeting 24 Mar 2026 3:22PM $0.061 $0.019 fallen by 68.85%
$14 Change in substantial holding 10 Mar 2026 4:21PM $0.067 $0.019 fallen by 71.64%
$14 MX1 - First Full Body CT Laboratory Test Bench Completed 10 Mar 2026 8:20AM $0.066 $0.019 fallen by 71.21%
$14 MX1 - December 2025 Half Year Results Presentation 27 Feb 2026 9:45AM $0.065 $0.019 fallen by 70.77%
$14 MX1 - Appendix 4D and Half Year Financial Statements 27 Feb 2026 9:45AM $0.065 $0.019 fallen by 70.77%
$14 MX1 - Response to Publication on Government Website 23 Feb 2026 9:40AM $0.070 $0.019 fallen by 72.86%

26 - 50 of 705 results

Page 2 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.